1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies
- Contribution to journal › Article
- 2024
-
Mark
Revival of recombinant IL-2 therapy–approaches from the past until today
- Contribution to journal › Scientific review
-
Mark
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways
- Contribution to journal › Article
-
Mark
Fine tuning of the innate and adaptive immune responses by Interleukin-2
- Contribution to journal › Article
-
Mark
IL-2-mediated hepatotoxicity : knowledge gap identification based on the irAOP concept
- Contribution to journal › Article
- 2023
-
Mark
Exploring Spatial Heterogeneity of Immune Cells in Nasopharyngeal Cancer
- Contribution to journal › Article
-
Mark
Upper airway microbiome transplantation for patients with chronic rhinosinusitis
- Contribution to journal › Article
- 2022
-
Mark
Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo-controlled crossover trial
- Contribution to journal › Article
-
Mark
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
- Contribution to journal › Article
- 2021
-
Mark
Tonsillar cancer with high cd8+ t‐cell infiltration features increased levels of dendritic cells and transcriptional regulation associated with an inflamed tumor microenvironment
- Contribution to journal › Article
